Patient Guide: An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 12 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06991556
Status: 🟢 Enrolling Now
Condition: Metastatic Hormone-sensitive Prostate Cancer
Phase: PHASE2

Where You Can Participate

This study is available at 12 locations across the country.

Top locations include:
  • • Omaha, Nebraska
  • • Myrtle Beach, South Carolina
  • • Nashville, Tennessee
  • • And 9 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC) - Join Clinical Trial NCTNCT06991556

How to Join This Clinical Trial - NCTNCT06991556

Learn how to participate in this PHASE2 trial studying an investigational therapy for Metastatic Hormone-sensitive Prostate Cancer. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Metastatic Hormone-sensitive Prostate Cancer. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Metastatic Hormone-sensitive Prostate Cancer
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06991556 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 12 locations. Find a study site near you:

Clinical Research Site

Omaha, Nebraska 68130 - United States

Status: RECRUITING

Clinical Research Site

Myrtle Beach, South Carolina 29572 - United States

Status: RECRUITING

Clinical Research Site

Nashville, Tennessee 37203 - United States

Status: RECRUITING

Clinical Research Site

San Antonio, Texas 78229 - United States

Status: RECRUITING

Clinical Research Site

Adelaide, South Australia 5000 - Australia

Status: RECRUITING

Clinical Research Site

Clayton, Victoria 3168 - Australia

Status: RECRUITING

Clinical Research Site

Nice, Alpes Maritimes 06189 - France

Status: RECRUITING

Clinical Research Site

Skorzewo, 60-185 - Poland

Status: RECRUITING

Clinical Research Site

Singapore, 169608 - Singapore

Status: RECRUITING

Clinical Research Site

Singapore, S308433 - Singapore

Status: RECRUITING

And 2 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Metastatic Hormone-sensitive Prostate Cancer:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships